Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3171047 | PMC |
| http://dx.doi.org/10.1136/bcr.07.2011.4458 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Renal manifestations of MGUS.
Hematology Am Soc Hematol Educ Program
December 2024
Department of Hematology and Cellular Therapy, Centre de référence maladies rares, Amylose AL et autres maladies par dépôts d'immunoglobulines monoclonales, Centre Hospitalier Universitaire Limoges, Université de Limoges, Limoges, France.
Kidney disease is a common complication of monoclonal immunoglobulin (MIg)-secreting B-cell disorders and predominantly occurs in patients who do not meet the criteria for an overt hematological disease. To distinguish this situation from monoclonal gammopathy of undetermined significance, which lacks organ damage, the term monoclonal gammopathy of renal significance (MGRS) was introduced to depict the association of a small, otherwise indolent B-cell clone, with renal disease induced by the secreted MIg. The spectrum of renal disorders in MGRS is wide, encompassing both tubular and glomerular disorders, classified according to the composition of deposits and their ultrastructural pattern of organization.
View Article and Find Full Text PDFin Shoulder Surgery: Is It a Significant Risk Factor for Postoperative Infection?
Clin Orthop Surg
December 2024
Department of Orthopedic Surgery, Konkuk University Medical Center, Seoul, Korea.
, a commensal, lipophilic, anaerobic Gram-positive bacterium, is well known for its potential to cause infections, particularly in the field of orthopedics, notably in the shoulder. However, its indolent strain nature presents challenges in the diagnosis of the bacterium using clinical, laboratory, and culture-based methods. There are controversies surrounding its actual threat as an infection-causing agent, leading to an incomplete consensus on treatment strategies after the infection.
View Article and Find Full Text PDFContinuing progress in radioimmunotherapy for hematologic malignancies.
Blood Rev
November 2024
Division of Hematopoiesis, Joint Research Center for Human Retrovirus Infection, Kumamoto University, 2-2-1 Honjo, Chuo-ku, Kumamoto 860-0811, Japan. Electronic address:
Radioimmunotherapy (RIT) involves combining a cytotoxic radionuclide with an antibody (Ab) targeting a tumor antigen. Compared with conventional therapies, RIT improves the therapeutic efficacy of Ab and ameliorates toxicity. This comprehensive review describes the current advancements and future prospects in RIT for treating hematologic malignancies based on recent investigations.
View Article and Find Full Text PDFControversies in the clinical management of chronic pulmonary aspergillosis.
Breathe (Sheff)
October 2024
Liverpool Hospital, Department of Respiratory and Sleep Medicine, Liverpool, Australia.
Article Synopsis
- * Treatment options for this condition include antifungal medications, minimally invasive procedures, and surgical interventions, though some patients may not be eligible for surgery due to their overall health.
- * Effective management, especially for more complicated cases, often requires a team-based approach due to the lack of extensive research and controlled studies.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!